ERBB2 and cancer: Our results demonstrated that ErbB2-overexpressing cancer cells (MDA-MB-435/ErbB2 and MCF7/ErbB2) were more sensitive to ganetespib than the parental cells (MDA-MB-435/Control and MCF7/Control), as indicated by both MTT and clonogenic assays (Fig. 6).